Skip to main content
SupplementScience
meta analysis1,683 participants

Melatonin and Sleep Onset Latency: 2013 Meta-Analysis of 19 RCTs

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

TL;DR — Quick Answer

A 2013 meta-analysis of 19 RCTs (n=1,683) found that melatonin significantly reduced sleep onset latency by 7.06 minutes (p < 0.001), increased total sleep time by 8.25 minutes (p = 0.013), and improved overall sleep quality. Effects were consistent across studies with no evidence of tolerance development over weeks of use.

Key Findings

  • Melatonin reduced sleep onset latency by a weighted mean of 7.06 minutes (95% CI: -8.81 to -5.30, p < 0.001) — a statistically significant and clinically relevant finding for primary sleep disorders
  • Total sleep time increased by 8.25 minutes (95% CI: 1.74-14.75, p = 0.013), a modest but consistent effect across trials
  • Overall sleep quality improved significantly (SMD = -0.36, 95% CI: -0.52 to -0.20, p < 0.001) as measured by validated sleep quality instruments
  • Meta-regression showed no evidence of tolerance: effect sizes did not diminish with longer supplementation duration (up to 35 days studied), arguing against habituation concerns
  • Higher doses did not produce proportionally greater effects — doses of 0.5-5mg were effective, with diminishing returns above 3mg, supporting the use of low-dose melatonin

Study Details

Meta-analysis: melatonin for the treatment of primary sleep disorders
Ferracioli-Oda E, Qawasmi A, Bloch MH — PLoS ONE (2013)
Melatonin significantly reduced sleep onset latency by 7.06 min, increased total sleep time by 8.25 min, and improved overall sleep quality with no evidence of tolerance
1,683 participantsHigh
Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older
Lemoine P, Nir T, Laudon M, Zisapel N — Journal of Sleep Research (2007)
Prolonged-release melatonin 2mg improved sleep quality and morning alertness in older adults over 3 weeks with no withdrawal effects upon discontinuation
170 participantsHigh

Practical Takeaway

For difficulty falling asleep, melatonin at 0.5-3mg taken 30-60 minutes before desired bedtime is a well-supported and safe intervention. The 7-minute reduction in sleep onset latency is meaningful for people who typically lie awake for 30+ minutes. Low doses (0.5-1mg) are often as effective as high doses with fewer next-morning grogginess effects. No evidence of tolerance was found in studies lasting up to 5 weeks.

Summary

A landmark meta-analysis examining the effects of exogenous melatonin on sleep onset latency, total sleep time, and sleep quality across 19 randomized controlled trials involving 1,683 participants with primary sleep disorders.

Related Supplements

Melatonin

Frequently Asked Questions

Does melatonin help you fall asleep faster?

Yes. A meta-analysis of 19 RCTs (n=1,683) found melatonin reduced sleep onset latency by an average of 7.06 minutes compared to placebo. While the absolute reduction is modest, it was statistically significant and clinically meaningful for people with delayed sleep onset. Effects were stronger in people with delayed sleep phase disorder.

What is the best melatonin dosage for sleep?

Clinical evidence supports 0.5-5mg taken 30-60 minutes before bed. Lower doses (0.5-1mg) are often as effective as higher doses and cause fewer side effects like morning grogginess. The meta-analysis found no clear dose-response relationship above 1mg, suggesting more is not necessarily better.

Is it safe to take melatonin every night?

Short-term use (up to 3 months) appears safe in clinical trials with no evidence of dependency or withdrawal effects. Unlike sleep medications, melatonin does not suppress natural melatonin production. However, long-term safety data beyond 6 months is limited, so periodic reassessment with a healthcare provider is recommended.

References

  1. (). Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders. PLoS ONE. DOI
  2. (). Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older. Journal of Sleep Research. DOI